Literature DB >> 2347905

Spontaneously occurring antibodies to parathyroid hormone.

M Wilkinson1, A McElduff, J Wilson, P Haber, A Freeman, M Robertson, P Mathews.   

Abstract

A 76-yr-old female with acute pancreatitis and a normal/borderline elevated serum calcium level was found to have an elevated immunoreactive circulating PTH concentration using a C-terminal assay. This high PTH concentration misled the attending physicians and resulted, in retrospect, in an unnecessary neck exploration. When the patient's serum was examined it was found to contain a binding component that bound both C-terminal and PTH-(1-84). This binding component was not retained on a Sep-Pak column and was precipitated by antiserum directed against human immunoglobulin M. The presence of circulating anti-PTH immunoglobulin M explains the apparently high PTH concentrations measured by RIA. The antibodies occurred spontaneously. To the best of our knowledge, this phenomenon has not previously been described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347905     DOI: 10.1210/jcem-70-6-1744

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels.

Authors:  B Cavaco; V Leite; M M Loureiro; M F Ferreira; M C Pereira; M A Santos; L G Sobrinho
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

2.  Antiidiotypic PTH antibodies as a cause of elevated immunoreactive parathyroid hormone in idiopathic hypoparathyroidism, a second case: another manifestation of autoimmune endocrine disease?

Authors:  A McElduff; M Lackmann; M Wilkinson
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

3.  Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon beta.

Authors:  G Fierlbeck; T Schreiner; B Schaber; A Walser; G Rassner
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.